'Freeze-All' Strategy Not Superior to Fresh Embryo Transfer in IVF
THURSDAY, Aug. 6, 2020 -- Fresh embryo transfer should be the gold standard for assisted reproduction among women with no immediate risk for ovarian hyperstimulation syndrome, according to a study published online Aug. 5 in The BMJ.
Sacha Stormlund, M.D., Ph.D., from Hvidovre University Hospital in Copenhagen, Denmark, and colleagues compared the ongoing pregnancy rate between women randomly assigned to assisted reproductive technology treatment with a freeze-all strategy with gonadotropin releasing hormone agonist triggering or a fresh transfer strategy with human chorionic gonadotropin triggering. The 460 women (aged 18 to 39 years) had regular menstrual cycles and were treated at one of eight outpatient fertility clinics in Denmark, Sweden, and Spain.
The researchers found that the ongoing pregnancy rate did not differ significantly between the freeze-all and fresh transfer groups (27.8 versus 29.6 percent; risk ratio, 0.98; 95 percent confidence interval, 0.87 to 1.10; P = 0.76). There were also no significant differences between the groups for the live birth rate (risk ratio, 0.98; 95 percent confidence interval, 0.87 to 1.10; P = 0.83). Further, there were no significant differences noted between groups for positive human chorionic gonadotropin rate or pregnancy loss, and there were no risks for pregnancy-related, obstetric, or neonatal complications. However, there was a higher mean birth weight after frozen blastocyst transfer and an increased risk for prematurity after fresh blastocyst transfer. Lastly, time to pregnancy was longer in the freeze-all group.
"The findings warrant caution in applying a freeze-all strategy in the broad in vitro fertilization population when no apparent risk of ovarian hyperstimulation syndrome is present," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2020 HealthDay. All rights reserved.
Posted: August 2020
Read this next
THURSDAY, June 25, 2020 -- For women with premature ovarian insufficiency (POI), continuous use of combined oral contraceptives (COC) is associated with increased bone mineral density...
WEDNESDAY, June 24, 2020 -- Prolonged storage of embryos after vitrification is associated with a reduced likelihood of biochemical pregnancy, clinical pregnancy, and live birth, according...
WEDNESDAY, June 17, 2020 -- Among women with a history of miscarriage or subfertility trying for a pregnancy, mild subclinical hypothyroidism (SCH) is common, according to a study published...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.